Velorum Therapeutics develops innovative therapies targeting heme biology to address unmet medical needs in diseases like porphyrias and cancer.
Founded
2023
Revenue
<$5M
Company Stage
Seed
YC Batch
W24
Product Features & Capabilities
cancer therapies targeting metabolic vulnerabilities, innovative treatments for porphyrias, drugs that disrupt tumor metabolism, therapies that unlock the biology of heme
